Mary T Szela Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Mary T Szela.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Mary T Szela. Mary T Szela is a Senior Vice President in ABBOTT LABORATORIES ($ABT) and an Chief Executive Officer in QLT INC/BC ($QLTI) and a Director in ALIMERA SCIENCES INC ($ALIM) and an Chief Executive Officer in Aegerion Pharmaceuticals, Inc. ($AEGR) and a Director in Kura Oncology, Inc. ($KURA) and a Director in Receptos, Inc. ($RCPT) and a Director in Coherus BioSciences, Inc. ($CHRS).

Address: 100 ABBOTT PARK ROAD ABBOTT PARK 60064-6400 IL

Companies in which Mary T Szela is an Insider

ABBOTT LABORATORIES

Trading Symbol: ABT
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mary T Szela: Senior Vice President
Holdings: 119,342 shares
Current Value: $5,118,578
Latest Transaction: Dec 16 2011
$ABT Market Capitalization: $62.37B
$ABT Previous Close: $42.89

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Aegerion Pharmaceuticals, Inc.

Trading Symbol: AEGR
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mary T Szela: Chief Executive Officer
Holdings: 0 shares
Latest Transaction: Nov 30 2016

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

ALIMERA SCIENCES INC

Trading Symbol: ALIM
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mary T Szela: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 21 2018
$ALIM Market Capitalization: $75.24M
$ALIM Previous Close: $1.16

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Coherus BioSciences, Inc.

Trading Symbol: CHRS
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Mary T Szela: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 19 2017
$CHRS Market Capitalization: $1.03B
$CHRS Previous Close: $26.65

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Kura Oncology, Inc.

Trading Symbol: KURA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mary T Szela: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Nov 08 2018
$KURA Market Capitalization: $124.74M
$KURA Previous Close: $6.20

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

NOVELION THERAPEUTICS INC.

Trading Symbol: NVLN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mary T Szela: Chief Executive Officer
Holdings: 6,632 shares
Latest Transaction: May 11 2017

Last 4 weeks trend: BUY
Last 3 months trend: BUY View transactions

Last 3 Months Overview:
Buy: 1x
Sell: 1x
Shares Bought: 6,632
Shares Sold: 2,248
Share Difference: +4,384
Value Difference: +$21,176

Receptos, Inc.

Trading Symbol: RCPT
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mary T Szela: Director
Holdings: 0 shares
Latest Transaction: Aug 27 2015

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Mary T Szela

Sentiment: All, ABT, AEGR, ALIM, CHRS, KURA, NVLN, RCPT

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Nov 08 2018KURAKura Oncology, Inc ...Szela Mary TDirectorOption ExerciseA11.557,58387,5847,583
Nov 08 2018KURAKura Oncology, Inc ...Szela Mary TDirectorOption ExerciseA11.5530,000346,50030,000
Jun 21 2018ALIMALIMERA SCIENCES I ...Szela Mary TDirectorOption ExerciseA0.8640,00034,40040,000
May 19 2017CHRSCoherus BioScience ...Szela Mary TDirectorOption ExerciseA23.8020,000476,00020,000
May 11 2017QLTINOVELION THERAPEUT ...Szela Mary TChief Executive Off ...Option ExerciseM0.006,632013,264
May 11 2017QLTINOVELION THERAPEUT ...Szela Mary TChief Executive Off ...Payment of ExerciseF9.422,24821,1764,3846.6 K to 4.4 K (-33.90 %)
May 11 2017QLTINOVELION THERAPEUT ...Szela Mary TChief Executive Off ...BuyM0.006,63206,6320 to 6.6 K

View all Mary T Szela insider transactions.